Clinical Trial Detail

NCT ID NCT03565835
Title Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Montefiore Medical Center
Indications

prostate adenocarcinoma

Therapies

Abiraterone + Prednisone

Age Groups: adult senior

No variant requirements are available.